Answer
The most common adverse reactions reported in clinical studies with Zavesca (miglustat) were diarrhoea, flatulence, abdominal pain, weight loss and tremor.
Sources for this answer
- Zavesca 100 mg capsules (Great Britain)Janssen-Cilag Ltd (a Johnson & Johnson Company) · emc · SmPC §4.8 Undesirable effects · Version 30Document updated
Sources checked